Keros doses first patient in Phase 2 trial of rinvatercept for Duchenne muscular dystrophySep 28Clinical readoutKeros Therapeutics, Inc.rinvatercept
Keros reports second-quarter 2026 results as Phase 2 rinvatercept DMD trial gets underwayAug 3Quarterly updateKeros Therapeutics, Inc.rinvatercept
Keros lists Phase 2 trial of KER-065 in Duchenne muscular dystrophy on ClinicalTrials.govJul 15Trial updateKeros Therapeutics, Inc.rinvatercept
Sign inSign in